New, needle-free approach aims to escape constant cycle of reactively “chasing” virus variants. This represents a fundamental new vaccine technology that could prevent future pandemics before they begin. The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine […]